ABBOTT LABORATORIES — Director's Dealing 2016

Jul 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-07-26

Reporting Person: Warmuth Michael J (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-26	Common shares without par value	M	26800	$25.2461	Acquired	81811	Direct
2016-07-26	Common shares without par value	S	11951	$43.48	Disposed	69860	Direct
2016-07-26	Common shares without par value	S	10349	$43.49	Disposed	59511	Direct
2016-07-26	Common shares without par value	S	4500	$43.50	Disposed	55011	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-26	Option (right to buy)	$25.2461	M	26800	Disposed	2017-02-15	Common shares (26800)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	29586	Indirect

Footnotes

F1: Held in the Stefanie M. Warmuth Revocable Trust. The reporting person and his spouse are trustees of the trust. The trust is revocable by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.